Cargando…

Interleukin-17 Expression in the Barrett's Metaplasia-Dysplasia-Adenocarcinoma Sequence

Introduction. This pilot study evaluated the expression of the proinflammatory cytokine IL-17 along the Barrett's metaplasia-dysplasia-adenocarcinoma sequence by establishing the expression levels of IL-17 in columnar epithelium, intestinal metaplastic cells, and dysplastic/glandular neoplastic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bannister, J. R., Khan, A. L., Eccleston, D. W., Deol-Poonia, R. K., Hughes, S. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765756/ https://www.ncbi.nlm.nih.gov/pubmed/24049650 http://dx.doi.org/10.5402/2012/578149

Ejemplares similares

Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence
por: Griffiths, E A, et al.
Publicado: (2007)

Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study
por: Markoš, Pave, et al.
Publicado: (2018)

Evolving management of metaplasia and dysplasia in Barrett's epithelium
por: Evans, Richard P T, et al.
Publicado: (2016)

Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences
por: Kuramochi, Hidekazu, et al.
Publicado: (2009)

Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
por: Soldes, O S, et al.
Publicado: (1999)

Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus
por: Volkweis, Bernardo Silveira, et al.
Publicado: (2012)

Frequent Occurrence of Mitochondrial DNA Mutations in Barrett’s Metaplasia without the Presence of Dysplasia
por: Lee, Soong, et al.
Publicado: (2012)

Barrett’s Esophagus and Intestinal Metaplasia
por: Zhang, Lu, et al.
Publicado: (2021)

Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma
por: Almhanna, Khaldoun, et al.
Publicado: (2016)

MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia
por: Fassan, Matteo, et al.
Publicado: (2013)

CD80 expression promotes immune surveillance in Barrett’s metaplasia
por: Scarpa, Melania, et al.
Publicado: (2019)

Length of Barrett’s esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma
por: Barrie, Jenifer, et al.
Publicado: (2020)

Comparative Multi-Epitope-Ligand-Cartography reveals essential immunological alterations in Barrett's metaplasia and esophageal adenocarcinoma
por: Berndt, Uta, et al.
Publicado: (2010)

Extensive telomere erosion is consistent with localised clonal expansions in Barrett’s metaplasia
por: Letsolo, Boitelo T., et al.
Publicado: (2017)

Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014)

Rab11 in dysplasia of Barrett's epithelia.
por: Goldenring, J. R., et al.
Publicado: (1999)

Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
por: Valdovinos-Andraca, Francisco, et al.
Publicado: (2023)

Treatment of Dysplasia in Barrett Esophagus
por: Aranda-Hernandez, Javier, et al.
Publicado: (2014)

Magnification Endoscopy and Chromoendoscopy in Evaluation of Specialized Intestinal Metaplasia in Barrett’s Esophagus
por: Wasielica-Berger, Justyna, et al.
Publicado: (2011)

Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett’s Esophagus
por: Jang, Bo Gun, et al.
Publicado: (2015)

Tenascin-C and fibronectin in normal esophageal mucosa, Barrett’s esophagus, dysplasia and adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2017)

Risk Factors for Progression of Barrett’s Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma
por: Kambhampati, Swetha, et al.
Publicado: (2020)

SPT6 loss permits the transdifferentiation of keratinocytes into an intestinal fate that resembles Barrett’s metaplasia
por: Vo, Daniella T., et al.
Publicado: (2021)

Endoscopic Ultrasound in Barrett's Oesophagitis with Dysplasia
por: Wray, Andrew, et al.
Publicado: (2012)

Gastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasia
por: Gomez, Justin M, et al.
Publicado: (2017)

Apoptotic activity is increased in parallel with the metaplasia–dysplasia–carcinoma sequence of the bronchial epithelium
por: Törmänen, U, et al.
Publicado: (1999)

TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)

CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer
por: Cappello, F, et al.
Publicado: (2005)

Barrett’s Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models
por: Korbut, Edyta, et al.
Publicado: (2022)

Mucosa-Associated Microbiota in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls
por: Peter, Shajan, et al.
Publicado: (2020)

Polypoidal Intestinal Metaplasia and Dysplasia of the External Urethral Meatus
por: Mathew, Mary, et al.
Publicado: (2012)

Circumferential endoscopic submucosal dissection for the treatment of ultra-short-segment Barrett’s adenocarcinoma with multifocal dysplasia
por: Emura, Fabian, et al.
Publicado: (2020)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Low-grade dysplasia on Barrett’s esophagus: visible or not ?
por: Barret, Maximilien
Publicado: (2023)

Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia
por: Kong, Jianping, et al.
Publicado: (2015)

CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer
por: Kang, Jung Mook, et al.
Publicado: (2011)

Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett’s esophagus may not be benign
por: Cameron, Georgina R., et al.
Publicado: (2016)

Laparoscopic Transhiatal Esophagectomy for Barrett's Esophagus with High Grade Dysplasia
por: Luketich, James D., et al.
Publicado: (1998)

Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.
por: Swift, A., et al.
Publicado: (1995)

Impact of the development of an endoscopic eradication program for Barrett’s esophagus with high grade dysplasia or early adenocarcinoma on the frequency of surgery
por: Chilukuri, Prianka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_it03n951ivnjppakjgi2njo786